Weber JS - Search Results

1

Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.

Koyanagi K, O'Day SJ, Boasberg P, Atkins MB, Wang HJ, Gonzalez R, Lewis K, Thompson JA, Anderson CM, Lutzky J, Amatruda TT, Hersh E, Richards J, Weber JS, Hoon DS. Koyanagi K, et al. Among authors: weber js. Clin Cancer Res. 2010 Apr 15;16(8):2402-8. doi: 10.1158/1078-0432.CCR-10-0037. Epub 2010 Apr 6. Clin Cancer Res. 2010. PMID: 20371696 Free PMC article.

2

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.

Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD, Roederer M, Davis MM. Lee PP, et al. Among authors: weber js. Nat Med. 1999 Jun;5(6):677-85. doi: 10.1038/9525. Nat Med. 1999. PMID: 10371507

3

Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.

Wang F, Bade E, Kuniyoshi C, Spears L, Jeffery G, Marty V, Groshen S, Weber J. Wang F, et al. Clin Cancer Res. 1999 Oct;5(10):2756-65. Clin Cancer Res. 1999. PMID: 10537339 Clinical Trial.

4

A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma.

Atkins MB, Redman B, Mier J, Gollob J, Weber J, Sosman J, MacPherson BL, Plasse T. Atkins MB, et al. Clin Cancer Res. 2001 Mar;7(3):486-92. Clin Cancer Res. 2001. PMID: 11297238 Clinical Trial.

5

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma.

Lee P, Wang F, Kuniyoshi J, Rubio V, Stuges T, Groshen S, Gee C, Lau R, Jeffery G, Margolin K, Marty V, Weber J. Lee P, et al. J Clin Oncol. 2001 Sep 15;19(18):3836-47. doi: 10.1200/JCO.2001.19.18.3836. J Clin Oncol. 2001. PMID: 11559721 Clinical Trial.

6

Dolastatin-10 in metastatic melanoma: a phase II and pharmokinetic trial of the California Cancer Consortium.

Margolin K, Longmate J, Synold TW, Gandara DR, Weber J, Gonzalez R, Johansen MJ, Newman R, Baratta T, Doroshow JH. Margolin K, et al. Invest New Drugs. 2001;19(4):335-40. doi: 10.1023/a:1010626230081. Invest New Drugs. 2001. PMID: 11561695 Clinical Trial.

7

Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery.

Yu C, Chen JC, Apuzzo ML, O'Day S, Giannotta SL, Weber JS, Petrovich Z. Yu C, et al. Among authors: weber js. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1277-87. doi: 10.1016/s0360-3016(01)02772-9. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955740

8

A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma.

Pullarkat V, Lee PP, Scotland R, Rubio V, Groshen S, Gee C, Lau R, Snively J, Sian S, Woulfe SL, Wolfe RA, Weber JS. Pullarkat V, et al. Among authors: weber js. Clin Cancer Res. 2003 Apr;9(4):1301-12. Clin Cancer Res. 2003. PMID: 12684398 Clinical Trial.

9

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma.

Tagawa ST, Lee P, Snively J, Boswell W, Ounpraseuth S, Lee S, Hickingbottom B, Smith J, Johnson D, Weber JS. Tagawa ST, et al. Among authors: weber js. Cancer. 2003 Jul 1;98(1):144-54. doi: 10.1002/cncr.11462. Cancer. 2003. PMID: 12833467 Free article. Clinical Trial.

10

Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study.

Liu D, O'Day SJ, Yang D, Boasberg P, Milford R, Kristedja T, Groshen S, Weber J. Liu D, et al. Clin Cancer Res. 2005 Feb 1;11(3):1237-46. Clin Cancer Res. 2005. PMID: 15709194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters